ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
July 2026
Nuclear Technology
June 2026
Fusion Science and Technology
May 2026
Latest News
North American construction is back—smaller and faster—at OPG’s Darlington
“The nuclear renaissance is real here,” said Ontario Power Generation’s Subo Sinnathamby on May 8, one year to the day after OPG secured a final investment decision to build the first of four planned BWRX-300 reactors at its Darlington nuclear power plant, and shortly after the new reactor’s foundation was lifted into place. “We got our license to construct in April and our [final investment decision] in May, and we’ve been off to the races since.”
Yoshihiro Nakane, Teruo Abe, Hiroshi Nakashima
Nuclear Technology | Volume 168 | Number 2 | November 2009 | Pages 519-523
Shielding | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (Part 2) / Accelerators | doi.org/10.13182/NT09-A9236
Articles are hosted by Taylor and Francis Online.
Radiation shielding calculations were performed for the shielding design around beam injection and beam extraction areas at the 3-GeV proton synchrotron in the Japan Proton Accelerator Research Complex (J-PARC) with the PHITS Monte Carlo code. Prompt dose rates outside the shields were obtained from calculated neutron energy spectra and flux-to-dose conversion coefficients prepared for the shielding design in J-PARC. The thicknesses of shields were determined from the comparison results of the prompt dose rates with the criteria of dose limit for the design in J-PARC.